Zhenghua Lu

Title: Innovations of Zhenghua Lu in Biotechnology

Introduction

Zhenghua Lu is a prominent inventor based in Jiangyin, China. He has made significant contributions to the field of biotechnology, particularly in the development of pharmaceutical compounds. With a total of 2 patents, his work focuses on innovative treatments for diseases modulated by specific biological pathways.

Latest Patents

Zhenghua Lu's latest patents include a selective CDK4/6 inhibitor and a preparation method thereof. This compound, represented by a specific formula, serves as a selective inhibitor of cyclin-dependent kinase 4/6 (CDK4/6). It has potential applications in treating or preventing diseases that are at least partially modulated by CDK4/6. Another notable patent involves 2-arylamino pyridine, pyrimidine, or triazine derivatives. These derivatives are designed to target certain mutated forms of the epidermal growth factor receptor (EGFR), such as the L858R activating mutant and the T790M resistance mutant. They may be utilized for the treatment and prevention of various cancers.

Career Highlights

Zhenghua Lu is currently associated with Wuxi Shuangliang Biotechnology Co., Ltd. His role in this company allows him to further his research and development efforts in the biotechnology sector. His innovative work has positioned him as a key figure in the industry.

Collaborations

Zhenghua Lu collaborates with notable colleagues, including Jian Dong and Jiaquan Wu. These partnerships enhance the research capabilities and foster innovation within their projects.

Conclusion

Zhenghua Lu's contributions to biotechnology through his patents and collaborations highlight his commitment to advancing medical treatments. His work continues to impact the field positively, paving the way for future innovations.